Jiangsu Hengrui Medicine Co Ltd Cash Flow Quality Index
Jiangsu Hengrui Medicine Co Ltd cash flow quality index. Jiangsu Hengrui Medicine Co Ltd (600276) has a Cash Flow Quality Index of 3.70x as of September 2025. Operating cash flow of CN¥4.81 Billion exceeds net income of CN¥1.30 Billion, indicating high earnings quality where cash backs reported profits. See Jiangsu Hengrui Medicine Co Ltd (600276) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Jiangsu Hengrui Medicine Co Ltd (1999–2024)
Cash flow quality index of Jiangsu Hengrui Medicine Co Ltd from 1999 to 2024. Historical Cash Flow Quality Index for Jiangsu Hengrui Medicine Co Ltd across 26 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore debt repayment capacity of Jiangsu Hengrui Medicine Co Ltd to assess how comfortably operating cash covers total debt obligations.
Jiangsu Hengrui Medicine Co Ltd Cash Flow Quality Index by Year (1999–2024)
Jiangsu Hengrui Medicine Co Ltd cash flow quality index by year from 1999 to 2024. Year-by-year earnings quality comparison for Jiangsu Hengrui Medicine Co Ltd. For the full cash flow conversion analysis, see Jiangsu Hengrui Medicine Co Ltd operating cash flow efficiency.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.17x | CN¥7.42 Billion | CN¥6.34 Billion | ▼ -34.4% |
| 2023 | 1.79x | CN¥7.64 Billion | CN¥4.28 Billion | ▲ +438.8% |
| 2022 | 0.33x | CN¥1.27 Billion | CN¥3.82 Billion | ▼ -64.8% |
| 2021 | 0.94x | CN¥4.22 Billion | CN¥4.48 Billion | ▲ +73.0% |
| 2020 | 0.54x | CN¥3.43 Billion | CN¥6.31 Billion | ▼ -24.1% |
| 2019 | 0.72x | CN¥3.82 Billion | CN¥5.33 Billion | ▲ +4.9% |
| 2018 | 0.68x | CN¥2.77 Billion | CN¥4.06 Billion | ▼ -11.7% |
| 2017 | 0.77x | CN¥2.55 Billion | CN¥3.29 Billion | ▼ -21.4% |
| 2016 | 0.98x | CN¥2.59 Billion | CN¥2.63 Billion | ▼ -3.9% |
| 2015 | 1.02x | CN¥2.28 Billion | CN¥2.22 Billion | ▲ +2.3% |
| 2014 | 1.00x | CN¥1.57 Billion | CN¥1.57 Billion | ▼ -5.3% |
| 2013 | 1.06x | CN¥1.36 Billion | CN¥1.29 Billion | ▲ +26.9% |
| 2012 | 0.83x | CN¥958.37 Million | CN¥1.15 Billion | ▲ +48.4% |
| 2011 | 0.56x | CN¥527.36 Million | CN¥940.41 Million | ▲ +9.8% |
| 2010 | 0.51x | CN¥385.95 Million | CN¥755.44 Million | ▼ -19.3% |
| 2009 | 0.63x | CN¥439.12 Million | CN¥693.30 Million | ▲ +134.9% |
| 2008 | 0.27x | CN¥117.46 Million | CN¥435.59 Million | ▼ -48.4% |
| 2007 | 0.52x | CN¥218.87 Million | CN¥418.53 Million | ▼ -59.7% |
| 2006 | 1.30x | CN¥266.18 Million | CN¥204.90 Million | ▼ -8.7% |
| 2005 | 1.42x | CN¥227.88 Million | CN¥160.07 Million | ▼ -17.5% |
| 2004 | 1.73x | CN¥209.41 Million | CN¥121.32 Million | ▲ +16.3% |
| 2003 | 1.48x | CN¥136.82 Million | CN¥92.20 Million | ▲ +136.0% |
| 2002 | 0.63x | CN¥49.84 Million | CN¥79.27 Million | ▲ +345.5% |
| 2001 | 0.14x | CN¥11.49 Million | CN¥81.40 Million | ▼ -52.8% |
| 2000 | 0.30x | CN¥19.61 Million | CN¥65.54 Million | ▼ -54.4% |
| 1999 | 0.66x | CN¥33.89 Million | CN¥51.65 Million | — |